dsm-firmenich to Launch Humiome B2, the “First Biotic Vitamin”
04.25.24
The B2 ingredient is designed to mostly release in the lower intestine, targeting the growth of beneficial bacteria.
Booth D90
Ingredient supplier dsm-firmenich will launch Humiome B2, “the world’s first ‘biotic’ vitamin,” at Vitafoods Europe. The new vitamin B2 ingredient is optimized for delivery to the colon, in order to deliver prebiotic-like benefits that support gut barrier integrity, immune function, mental well-being, and metabolic health.
Traditional vitamin B2 ingredients are mostly absorbed in the small intestine, but Humiome B2 releases in the lower intestine and colon at a 90% rate. The remaining 10% is utilized through absorption in the small intestine.
The vitamin B2 ingredient is formulated through the company’s proprietary Microbiome Targeted Technology, a dual-action delivery system featuring a two-layer natural coating. The first coating protects a riboflavin core from the harsh, acidic environment of the stomach and small intestine. The outer layer then withstands digestive enzymes and low pH, while the inner layer remains intact until it reaches the colon. There, it dissolves and releases riboflavin to nourish and support the growth of beneficial bacteria, provide detoxification, and reduce reactive oxygen species.
“As the first product in our Humiome portfolio to feature Microbiome Targeted Technology, which is backed by extensive preclinical and human clinical studies, we are confident that Humiome B2 will help our customers address the needs of consumers seeking holistic health from the gut solutions,” said Ruedi Duss, global gut and metabolic lead at dsm-firmenich. “As well as maximizing the bioavailability of riboflavin in the colon to nourish the gut microbiome, Humiome B2 with MTT, the first ‘biotic’ vitamin, can work alongside other gut health enablers including pro-, pre-, and postbiotics and human milk oligosaccharides. The solution also offers multiple functional benefits for formulators, such as enhancing vitamin stability by protecting against humidity, light, and oxygen.”
Humiome B2 is designed to support the key pillars of the gut ecosystem, including a healthy gut environment, the growth of keystone species, gut barrier integrity, and microbiome-independent mechanisms. The ingredient will launch initially in Europe, the Middle East, Africa, and North America, with more regions to follow.
Robert E. Steinert, PD, HNC principal scientist at dsm-firmenich, will give a presentation on the science behind Humiome B2 at the Probiotics Theater on May 14, 11:30-11:55 CET.
Ingredient supplier dsm-firmenich will launch Humiome B2, “the world’s first ‘biotic’ vitamin,” at Vitafoods Europe. The new vitamin B2 ingredient is optimized for delivery to the colon, in order to deliver prebiotic-like benefits that support gut barrier integrity, immune function, mental well-being, and metabolic health.
Traditional vitamin B2 ingredients are mostly absorbed in the small intestine, but Humiome B2 releases in the lower intestine and colon at a 90% rate. The remaining 10% is utilized through absorption in the small intestine.
The vitamin B2 ingredient is formulated through the company’s proprietary Microbiome Targeted Technology, a dual-action delivery system featuring a two-layer natural coating. The first coating protects a riboflavin core from the harsh, acidic environment of the stomach and small intestine. The outer layer then withstands digestive enzymes and low pH, while the inner layer remains intact until it reaches the colon. There, it dissolves and releases riboflavin to nourish and support the growth of beneficial bacteria, provide detoxification, and reduce reactive oxygen species.
“As the first product in our Humiome portfolio to feature Microbiome Targeted Technology, which is backed by extensive preclinical and human clinical studies, we are confident that Humiome B2 will help our customers address the needs of consumers seeking holistic health from the gut solutions,” said Ruedi Duss, global gut and metabolic lead at dsm-firmenich. “As well as maximizing the bioavailability of riboflavin in the colon to nourish the gut microbiome, Humiome B2 with MTT, the first ‘biotic’ vitamin, can work alongside other gut health enablers including pro-, pre-, and postbiotics and human milk oligosaccharides. The solution also offers multiple functional benefits for formulators, such as enhancing vitamin stability by protecting against humidity, light, and oxygen.”
Humiome B2 is designed to support the key pillars of the gut ecosystem, including a healthy gut environment, the growth of keystone species, gut barrier integrity, and microbiome-independent mechanisms. The ingredient will launch initially in Europe, the Middle East, Africa, and North America, with more regions to follow.
Robert E. Steinert, PD, HNC principal scientist at dsm-firmenich, will give a presentation on the science behind Humiome B2 at the Probiotics Theater on May 14, 11:30-11:55 CET.
